Abcam, ab289019, Human TLR1 knockout A549 cell line

Size: 1000000Cells / vial
TLR1 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control available. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:A549,
Species or organism:Human,
Tissue:Lung,
Form:LiquidSee storage information,
Knockout validation:Next Generation Sequencing,
Disease:Carcinoma

Product details:
Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.
Recommended control
: Human wild-type A549 cell line (ab288558). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-TLR1, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Next Generation Sequencing, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Toll-like receptor 1 (TLR1) also known as TIL plays a significant role in the immune system. It is a pattern recognition receptor that detects pathogen-associated molecular patterns (PAMPs). TLR1 has a molecular weight of approximately 90 kilodaltons. It is expressed on the surface of various immune cells including monocytes macrophages and dendritic cells. TLR1 recognizes triacylated lipopeptides in combination with TLR2 forming a heterodimer that is essential for signaling. This interaction enhances the immune response against microbial infections.
Biological function summary
TLR1 contributes to the immune response by participating in the detection of bacterial lipoproteins. This receptor is a part of the Toll-like receptor family which plays an essential role in innate immunity. TLR1 often in complex with TLR2 helps in recognizing and responding to the structural motifs of microbial pathogens. These interactions lead to the activation of downstream signaling pathways triggering the production of cytokines and other mediators essential for inflammatory responses.
Pathways
TLR1 is involved in the Toll-like receptor signaling pathway and the NF-kB signaling pathway. In the Toll-like receptor pathway TLR1-TLR2 heterodimers signal through adaptor proteins like MyD88 which leads to the activation of transcription factors such as NF-kB. This mechanism regulates the expression of genes involved in immune and inflammatory responses. TLR1 coordinates with TLR2 not just in recognition of ligands but also in the signaling to produce a coordinated immune response enhancing the cell's ability to deal with infections.
TLR1 plays a role in conditions involving immune dysregulation such as tuberculosis and sepsis. Genetic variations in TLR1 can impact susceptibility to these diseases by altering the receptor's ability to recognize pathogenic components. TLR1's interaction with TLR2 influences the inflammatory response and may contribute to inappropriate immune activation seen in sepsis. These receptors' roles in inflammation and pathogen recognition highlight their importance in understanding the development and progression of immune-related diseases.